These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35604870)

  • 1. Trends in methamphetamine use, markets and harms in Australia, 2003-2019.
    Man N; Sisson SA; McKetin R; Chrzanowska A; Bruno R; Dietze PM; Price O; Degenhardt L; Gibbs D; Salom C; Peacock A
    Drug Alcohol Rev; 2022 Jul; 41(5):1041-1052. PubMed ID: 35604870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in cocaine use, markets and harms in Australia, 2003-2019.
    Man N; Chrzanowska A; Price O; Bruno R; Dietze PM; Sisson SA; Degenhardt L; Salom C; Morris L; Farrell M; Peacock A
    Drug Alcohol Rev; 2021 Sep; 40(6):946-956. PubMed ID: 33626201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystalline methamphetamine use and methamphetamine-related harms in Australia.
    Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD
    Drug Alcohol Rev; 2017 Mar; 36(2):160-170. PubMed ID: 27286742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions.
    Price O; Man N; Sutherland R; Bruno R; Dietze P; Salom C; Agramunt S; Grigg J; Degenhardt L; Peacock A
    Int J Drug Policy; 2023 Mar; 113():103976. PubMed ID: 36822010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20.
    Price O; Man N; Bruno R; Dietze P; Salom C; Lenton S; Grigg J; Gibbs D; Wilson T; Degenhardt L; Chan R; Thomas N; Peacock A
    Addiction; 2022 Jan; 117(1):182-194. PubMed ID: 34159666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia.
    Scott N; Caulkins JP; Ritter A; Quinn C; Dietze P
    Addiction; 2015 Jan; 110(1):120-8. PubMed ID: 25220170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in treatment episodes for methamphetamine smoking and injecting in Australia, 2003-2019.
    McKetin R; Chrzanowska A; Man N; Peacock A; Sutherland R; Degenhardt L
    Drug Alcohol Rev; 2021 Nov; 40(7):1281-1286. PubMed ID: 33641198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of poisoning deaths with wastewater-based consumption estimates and assessment of fatal toxicity for amphetamine-type stimulant drugs.
    Kriikku P; Kankaanpää A; Gunnar T; Ojanperä I
    Drug Test Anal; 2024 Jun; 16(6):641-649. PubMed ID: 37933709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users.
    Leslie EM; Smirnov A; Cherney A; Wells H; Legosz M; Kemp R; Najman JM
    Addict Behav; 2017 Jul; 70():27-34. PubMed ID: 28182965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis.
    Chen C; Kostakis C; Harpas P; Felgate PD; Irvine RJ; White JM
    J Stud Alcohol Drugs; 2011 Sep; 72(5):737-40. PubMed ID: 21906501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of trends in wastewater-based data and traditional epidemiological indicators of stimulant consumption in three locations.
    Goulding N; Hickman M; Reid M; Amundsen EJ; Baz-Lomba JA; O'Brien JW; Tscharke BJ; de Voogt P; Emke E; Kuijpers W; Hall W; Jones HE
    Addiction; 2020 Mar; 115(3):462-472. PubMed ID: 31633843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent trends in the availability and use of amphetamine and methamphetamine in Norway.
    Bramness JG; Reid MJ; Solvik KF; Vindenes V
    Forensic Sci Int; 2015 Jan; 246():92-7. PubMed ID: 25485948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injecting drug use opportunities and reasons for choosing not to inject: A population-based study of Australian young adults who use stimulants.
    Casey LE; Pourmarzi D; Wessel EL; Kemp R; Smirnov A
    Drug Alcohol Rev; 2022 May; 41(4):873-882. PubMed ID: 35139243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The recent expansion in the Australian cocaine market: who are the new users and what are the harms?
    Chalmers J; Matthew-Simmons F; Hughes CE
    Curr Drug Abuse Rev; 2013 Jun; 6(2):98-111. PubMed ID: 24308523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Driving under the influence of central stimulant amines: age and gender differences in concentrations of amphetamine, methamphetamine, and ecstasy in blood.
    Jones AW; Holmgren A; Kugelberg FC
    J Stud Alcohol Drugs; 2008 Mar; 69(2):202-8. PubMed ID: 18299760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Trends in Alcohol and Other Drug Use Among Police Detainees in New Zealand, 2010-2015.
    Wilkins C; Prasad J; Parker K; Rychert M; Barnes HM
    Curr Top Behav Neurosci; 2017; 34():161-172. PubMed ID: 28434182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the Queensland 2007-2012 roadside drug testing program: The prevalence of three illicit drugs.
    Davey J; Armstrong K; Martin P
    Accid Anal Prev; 2014 Apr; 65():11-7. PubMed ID: 24389088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.